Reebye et al. [14] generated short-activating RNAs (saRNA) molecules to upregulate transcript levels of C/EBPα and reported reduced tumor burden and improved liver function in a liver cirrhosis/HCC model. This evidence concerns the gene CEBPA and neoplasm.